2ayr
From Proteopedia
A SERM Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus and Ovaries in Rats
Overview
The design of a novel selective estrogen receptor modulator (SERM) for the potential treatment of uterine leiomyoma is described. 16 (LY2066948-HCl) binds with high affinity to estrogen receptors alpha and beta (ERalpha and ERbeta, respectively) and is a potent uterine antagonist with minimal effects on the ovaries as determined by serum biomarkers and histologic evaluation.
About this Structure
2AYR is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats., Hummel CW, Geiser AG, Bryant HU, Cohen IR, Dally RD, Fong KC, Frank SA, Hinklin R, Jones SA, Lewis G, McCann DJ, Rudmann DG, Shepherd TA, Tian H, Wallace OB, Wang M, Wang Y, Dodge JA, J Med Chem. 2005 Nov 3;48(22):6772-5. PMID:16250633 Page seeded by OCA on Sat May 3 19:38:16 2008
Categories: Homo sapiens | Single protein | Bryant, H U. | Cohen, I R. | Dally, R D. | Dodge, J A. | Fong, K C. | Frank, S A. | Geiser, A G. | Hinklin, R. | Hummel, C W. | Jones, S A. | Lewis, G. | McCann, D J. | Rudman, D G. | Shepherd, T A. | Tian, H. | Wallace, O B. | Wang, Y. | Ligand-binding | Receptor | Serm | Transcription | Transcription regulation
